Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency
Enrica Ee Kar Tan,Richard Hopkins,Chrissie K. Lim,Saumya Jamuar,Christina Ong,Koh Cheng Thoon,Mark J.A. Koh,Eun Myoung Shin,Derrick Wen Quan Lian,Madhushanee Weerasooriya,Christopher Z.W Lee,Andreas Alvin Purnomo Soetedjo,Chang Siang Lim,Veronica B. Au,Edmond Chua,Hui Yin Lee,Leigh Ann Jones,Sharmy Jennifer James,Nivashini Kaliaperumal,Jeffrey Kwok,Ee Shien Tan,Biju Thomas,Lena Ho,Lynn Wu,Anna-Marie Fairhurst,Florent Ginhoux,Adrian K.K. Teo,Yongliang Zhang,Kok Haur Ong,Weimiao Yu,Byrappa Venkatesh,Vinay Tergaonkar,Bruno Reversade,Keh-Chuang Chin,Ah Moy Tan,Woei Kang Liew,John E. Connolly,Enrica E.K. Tan,Richard A. Hopkins,Saumya S. Jamuar,Koh C. Thoon,Eun Mong Shin,Derrick W.Q. Lian,Christopher Z.W. Lee,Andreas Alvin Pumomo Soetedjo,Veonice B. Au,Sharmy S. James,Jeffery Kwok,Lynn Xue Wu,Anna Marie Fairhurst,Yong Liang Zhang,Kok Huar Ong,Keh Chuang Chin
DOI: https://doi.org/10.1172/jci98882
IF: 19.456
2020-09-28
Journal of Clinical Investigation
Abstract:Although IKK-β has previously been shown as a negative regulator of IL-1β secretion in mice, this role has not been proven in humans. Genetic studies of NF-κB signaling in humans with inherited diseases of the immune system have not demonstrated the relevance of the NF-κB pathway in suppressing IL-1β expression. Here, we report an infant with a clinical pathology comprising neutrophil-mediated autoinflammation and recurrent bacterial infections. Whole-exome sequencing revealed a de novo heterozygous missense mutation of <i>NFKBIA</i>, resulting in a L34P IκBα variant that severely repressed NF-κB activation and downstream cytokine production. Paradoxically, IL-1β secretion was elevated in the patient's stimulated leukocytes, in her induced pluripotent stem cell–derived macrophages, and in murine bone marrow–derived macrophages containing the L34P mutation. The patient's hypersecretion of IL-1β correlated with activated neutrophilia and liver fibrosis with neutrophil accumulation. Hematopoietic stem cell transplantation reversed neutrophilia, restored a resting state in neutrophils, and normalized IL-1β release from stimulated leukocytes. Additional therapeutic blockade of IL-1 ameliorated liver damage, while decreasing neutrophil activation and associated IL-1β secretion. Our studies reveal a previously unrecognized role of human IκBα as an essential regulator of canonical NF-κB signaling in the prevention of neutrophil-dependent autoinflammatory diseases. These findings also highlight the therapeutic potential of IL-1 inhibitors in treating complications arising from systemic NF-κB inhibition.
medicine, research & experimental